CCO Secures Long-Term Kava Supply Agreement
Released
Released
Announcement PDF
The Calmer Co International Limited
24 Cansdale St, Yeronga Queensland 4104
ACN: 169 441 874
06 August 2026 ASX RELEASE
The Calmer Co. Secures Long-Term Kava Supply
Agreement to Support Growing Demand
Brisbane, Australia – The Calmer Co. International Limited (ASX: CCO), a leading
consumer packaged goods company specialising in kava and other natural products that
promote relaxation and sleep support, ispleased to announce the execution of a Strategic
Supply Agreement with a leading Pacific-based supplier of premium noble kava (the
"Supplier"), securing long-term access to premium noble kava sourced from Papua New
Guinea and Vanuatu.
The Agreement provides for the Supplier to hold reserved minimum monthly supply
capacity of premium noble kava for The Calmer Co., with an indicative annual supply value
of approximately A$8.65 million, strengthening the Company's existing Pacific sourcing
network and representing another important milestone in its strategy to build an
integrated kava supply chain supporting premium consumer products, botanical
ingredients and future manufacturing growth.
Strategic Highlights
• Long-term Strategic Supply Agreement executed with a leading Pacific-based
supplier of premium noble kava.
• Minimum reserved supply capacity of 10 tonnes per month of premium noble kava
from Papua New Guinea and Vanuatu, held by the Supplier for The Calmer Co.
• Indicative annual supply value of approximately A$8.65 million, based on reserved
minimum monthly capacity.
• Complements The Calmer Co.'s existing Pacific sourcing network, further
diversifying procurement across Fiji, Papua New Guinea and Vanuatu.
• Supports the Company's existing manufacturing capacity of approximately five
tonnes of dried kava per week, with additional manufacturing capability expected to
become available through the previously announced Heads of Agreement with
Kaiming Agro, subject to completion of definitive agreements.
• Establishes a comprehensive quality assurance framework, including agreed
product specifications, Certificates of Analysis, laboratory testing and supplier
performance standards.
• Enhances long-term supply security for the Company's branded consumer products
and growing botanical ingredients business.
• Reinforces The Calmer Co.'s vertically integrated strategy of creating greater value
from premium Pacific kava.
2
Strengthening an Integrated Pacific Supply Chain
Chief Executive Officer Zane Yoshida said the Agreement was an important strategic step
in strengthening the Company's upstream supply chain while supporting its broader
transformation strategy.
"Securing reliable, long-term access to premium noble kava is fundamental to our growth
strategy. This agreement strengthens our sourcing capability across the Pacific, enhances
supply chain resilience and provides greater confidence as we continue expanding our
manufacturing capability and global commercial presence."
"Importantly, this agreement complements the strategic initiatives we have announced
over recent months by strengthening the supply foundation required to support future
value-added manufacturing. It reflects our disciplined approach to building an integrated
Pacific kava business capable of delivering long-term value for shareholders while
supporting sustainable industry growth throughout the region."
The Agreement complements The Calmer Co.'s existing procurement activities in Fiji by
expanding long-term sourcing arrangements into Papua New Guinea and Vanuatu.
Together, these three Pacific origins provide the Company with greater procurement
flexibility, enhanced supply resilience and access to premium noble kava to support
increasing global demand across both branded consumer products and wholesale
botanical ingredients.
Strategic Supply Agreement
Under the Agreement, the Supplier will supply The Calmer Co. with a minimum of five
tonnes per month of premium noble kava from Papua New Guinea and five tonnes per
month from Vanuatu, representing a combined minimum reserved supply capacity of 10
tonnes per month held by the Supplier for The Calmer Co.
This reserved capacity represents a supply-side commitment by the Supplier and does not
constitute a minimum purchase obligation on the part of The Calmer Co., which retains full
discretion over order volumes and timing under the Agreement.
The Supplier is an established Pacific-based supplier of premium noble kava with annual
turnover of approximately A$38 million, reflecting its scale and standing as a strategic
sourcing partner.
The Agreement has an indicative annual supply value of approximately A$8.65 million
based on the reserved minimum monthly capacity, reflecting the Supplier's role as a
strategic partner supporting The Calmer Co.'s long-term procurement strategy.
In addition to supply commitments, the Agreement incorporates comprehensive quality
management procedures, including agreed product specifications, sampling protocols,
3
Certificates of Analysis, laboratory testing requirements, packaging and storage standards,
and annual supplier performance reviews. These measures are designed to ensure
consistency, traceability and quality across the Company's expanding Pacific sourcing
network.
Supporting Manufacturing Growth
The Agreement complements The Calmer Co.'s existing Pacific sourcing operations and
supports its manufacturing capability of approximately five tonnes of dried kava per week.
By securing additional long-term access to premium noble kava from Papua New Guinea
and Vanuatu, the Company is strengthening the raw material foundation required to
support continued growth across its branded consumer products and botanical
ingredients businesses.
The Agreement also complements the Company's previously announced Heads of
Agreement with Kaiming Agro by strengthening the upstream supply chain supporting its
broader strategy to increase value-added manufacturing in Fiji. Together, these initiatives
demonstrate continued execution of the Company's strategy to build an integrated Pacific
kava business spanning sourcing, manufacturing and global commercialisation.
Strengthening Pacific Supply Chain Resilience
The Calmer Co. has developed one of the most diversified premium kava sourcing
networks in the Pacific, with procurement spanning Fiji, Papua New Guinea and Vanuatu.
This diversified sourcing strategy reduces reliance on any single origin, enhances
procurement flexibility and strengthens the Company's ability to meet increasing global
demand for premium noble kava.
The Agreement further supports The Calmer Co.'s commitment to working with trusted
regional suppliers while promoting sustainable industry development and long-term
supply security throughout the Pacific.
Supporting Regional Kava Quality Standards
The Company's diversified sourcing strategy is further supported by regional industry
developments, including the Pacific Regional Kava Development Strategy (2024–2028) and
the associated Pacific Regional Kava Standard Project, collaborative initiatives led by the
Pacific Islands Forum Secretariat and Pacific Community to harmonise quality and
production standards across Fiji, Papua New Guinea, Vanuatu and other Pacific kava-
producing nations.
4
The Company's Founder and CEO, Zane Yoshida, participated in the inaugural meeting of
the Pacific Islands Standards Committee's Technical Committee 3 (TC3) on Kava Standards,
held in Sydney in April 2026 in partnership with the Pacific Islands Forum Secretariat and
supported by Standards Australia and the Australian Department of Foreign Affairs and
Trade. This reflects the Company's active engagement in regional efforts to develop
harmonised quality and production standards for kava across the Pacific, complementing
The Calmer Co.'s own sourcing and quality assurance capabilities.
Quality Assurance Framework
Maintaining consistent quality remains central to The Calmer Co.'s commercial strategy.
The Agreement establishes agreed quality standards covering product specifications,
Certificates of Analysis, laboratory testing, sampling procedures, traceability and ongoing
supplier performance monitoring.
These quality systems are designed to support customer confidence across both branded
consumer products and botanical ingredient sales while reinforcing the Company's
reputation as a supplier of premium Pacific kava.
Strategic Significance
This Agreement reflects an important step in The Calmer Co.'s evolving, vertically-
integrated operating model across the Pacific kava value chain, from diversified grower
relationships in Fiji, Papua New Guinea and Vanuatu, through strategic procurement
agreements such as this Agreement with the Supplier, to scientific quality assurance via the
Company's GC-MS laboratory capability, advanced manufacturing through strategic
partners including KAPPL, and ultimately premium branded consumer products and
botanical ingredients sold into global retail, food, beverage and ingredients markets.
This model allows The Calmer Co. to secure reliable access to premium raw materials and
manufacturing capability through strategic partnerships, while concentrating the
Company's own capital and management focus on product innovation, brand-building and
global commercialisation.
ASX Compliance Disclosure
Pursuant to ASX Compliance Update 02/25, the Company:
• does not consider the identity of the Supplier to the Agreement to be information
that a reasonable person would expect to have a material effect on the price or
value of the Company's securities;
5
• confirms that this announcement contains all material information relevant to
assessing the impact of the Agreement on the price or value of the Company's
securities, and is not misleading by omission; and
• confirms that it has conducted due diligence enquiries into the Supplier and is
satisfied with its standing and creditworthiness to perform its obligations to the
Company.
Please interact with management about this announcement via Investor Hub Link here:
This announcement has been approved by the Board of Directors.
ends
For further information
Investor & Media Relations
Zane Yoshida
investors@thecalmerco.com
About The Calmer Co.
The Calmer Co. International Limited (ASX:CCO) is a fast growing beverage business
leveraging a global opportunity in kava and other natural products that replace alcohol and
support relaxation and sleep.
Our products are delivered to consumers globally through e-commerce channels and blue-
chip retail distribution partners, supported by a reliable farm to shelf supply chain.
The product range includes drinking powders, natural and flavoured kava shots,
concentrates and capsules, sold under the brands Fiji Kava®
, Taki Mai®
and Danodan
Hempworks in markets including USA, Australia, New Zealand, China and the Pacific
Islands.
Forward looking statements
This ASX release includes certain forward-looking statements that are based on
information and assumptions known to date and are subject to various risks and
uncertainties. Actual results, performance or achievements could be significantly different
from those expressed in, or implied by, these forward-looking statements. Such forward-
looking statements are not guarantees of future performance and involve known and
unknown risks, uncertainties and other factors, many of which are beyond the control of
the Company. These factors may cause actual results to differ materially from those
expressed in the statements contained in this announcement.
Share your feedback
Discover